AN2 Therapeutics Inc. (ANTX)
New Form 8-K - AN2 Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143187 Size: 257 KB Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
New Form 8-K - AN2 Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143187 Size: 257 KB Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
There are no comments here yet...